Patient with Vulnerable Coronary Plaque and Treatment with Evolocumab: A Clinical Case
Journal of Clinical Medicine · 14.02.2025 · 14 (4) · 1257
DOI: 10.3390/jcm14041257 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Clinical Medicine, online erschienen am 14.02.2025. Verfasst von Lucio Addeo und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Advanced Biomedical Sciences, University of Naples Federico II, Via Sergio Pansini, 80131 Naples, Italy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CardioPath program at Federico II University of Naples, Università degli Studi di Milano.
Abstract (Originalsprache)
Background/Objectives: Vulnerable coronary plaques are strongly associated with acute coronary events, posing significant therapeutic challenges despite statin therapy. This case report evaluates the impact of Evolocumab, a PCSK-9 inhibitor, on stabilizing high-risk plaques and promoting phenotypic transformation, assessed through coronary CT angiography (CCTA).
Methods
A 50-year-old male with chronic coronary syndrome and a history of myocardial infarction underwent a CCTA, revealing a high-risk plaque (approximately 50%) in the proximal LAD. Despite achieving LDL-C targets with statin therapy, the plaque showed vulnerability features. Evolocumab (140 mg subcutaneously every two weeks) was added to therapy, combined with dietary counseling and dual antiplatelet therapy.
Results
A follow-up CCTA at 24 months demonstrated significant reductions in plaque volume and positive remodeling, with a transformation from a mixed phenotype to a predominantly calcified plaque. LDL-C levels decreased from 71 mg/dL to 18 mg/dL. The patient remained asymptomatic, with no cardiovascular events reported during the follow-up.
Conclusions
This case highlights the role of PCSK-9 inhibitors in stabilizing high-risk plaques, achieving structural changes that promote stability beyond LDL-C reduction. Advanced imaging techniques such as CCTA proved essential for risk stratification and monitoring therapy efficacy. Evolocumab offers a promising adjunctive treatment for high-risk patients unsuitable for elective revascularization, potentially redefining the standard of care for plaque stabilization in this setting.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Advanced Biomedical Sciences, University of Naples Federico II, Via Sergio Pansini, 80131 Naples, Italy.
- U.O Cardiologia, Clinica Sanatrix, Centro Studi SICOA, 80127 Naples, Italy.
- Dipartimento di Cardiologia, Pineta Grande Hospital, Castel Volturno, 81030 Caserta, Italy.
- IRCCS SYNLAB SDN, Via Emanuele Gianturco 113, 80143 Naples, Italy.
- Unità di Imaging Cardiovascolare Avanzato, Clinica Villa dei Fiori, Acerra, 80011 Naples, Italy.
- Unità di Radiologia, Pineta Grande Hospital, Castel Volturno, 81030 Caserta, Italy.
ORCID-Profile: Lucio Addeo, Stefano Nardi, Alessandra Scatteia, Antonio Rapacciuolo, Salvatore Giordano, Laura Adelaide Dalla Vecchia, Francesco Donatelli
Förderung
- CardioPath program at Federico II University of Naples
- Università degli Studi di Milano
Zitieren
APA
Addeo, L., Guarini, P., Campana, P., Argenziano, L., Nardi, S., Tedeschi, C., Scatteia, A., Silvestre, M., Rapacciuolo, A., Esposito, G., Giordano, S., Dalla Vecchia, L. A., & Donatelli, F. (2025). Patient with Vulnerable Coronary Plaque and Treatment with Evolocumab: A Clinical Case. Journal of Clinical Medicine, 14(4), 1257. https://doi.org/10.3390/jcm14041257
Vancouver
Addeo L, Guarini P, Campana P, Argenziano L, Nardi S, Tedeschi C, et al. Patient with Vulnerable Coronary Plaque and Treatment with Evolocumab: A Clinical Case. Journal of Clinical Medicine. 2025;14(4):1257. doi:10.3390/jcm14041257
BibTeX
@article{Addeo2025,
author = {Addeo, Lucio and Guarini, Pasquale and Campana, Pasquale and Argenziano, Luigi and Nardi, Stefano and Tedeschi, Carlo and Scatteia, Alessandra and Silvestre, Mattia and Rapacciuolo, Antonio and Esposito, Giovanni and Giordano, Salvatore and Dalla Vecchia, Laura Adelaide and Donatelli, Francesco},
title = {Patient with Vulnerable Coronary Plaque and Treatment with Evolocumab: A Clinical Case},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {4},
pages = {1257},
doi = {10.3390/jcm14041257}
}
EUVIMED